Millennium Management LLC 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-07-06 5:29 pm Sale | 2026-06-30 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Millennium Management LLC | 9,857 0.000% | -924,572 (-98.95%) | Filing |
| 2026-02-24 4:48 pm Purchase | 2026-02-17 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Millennium Management LLC | 934,429 5.000% | 47,155 (+5.31%) | Filing |
| 2026-02-17 4:11 pm Sale | 2026-02-10 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Millennium Management LLC | 887,274 4.800% | -19,488 (-2.15%) | Filing |
| 2026-02-10 4:07 pm Purchase | 2026-02-03 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Millennium Management LLC | 906,762 4.900% | 964 (+0.11%) | Filing |
| 2026-02-03 5:19 pm Purchase | 2026-01-28 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Millennium Management LLC | 905,798 4.900% | 905,798 (New Position) | Filing |